In the present study, we demonstrate that ephrin-A5 is able to induce a transient increase of MAP kinase activity in PC12 cells. However, the effects of ephrin-A5 on the MAP kinase signaling pathway are about three-fold less than that of EGF. In addition, we demonstrate that EphA4 is the only Eph member expressed in PC12 cells, and that tyrosine phosphorylation induced by ephrin-A5 treatment is consistent with the magnitude and longevity of MAP kinase activation. Experiments using the Ras dominant negative mutant N17Ras reveal that Ras plays a pivotal role in ephrin-A5-induced MAP kinase activation in PC12 cells. Importantly, we found that the EphA4 receptor is rapidly internalized by endocytosis upon engagement of ephrin-A5, leading to a subsequent reduction in the MAP kinase activation. Together, these data suggest a novel regulatory mechanism of differential Ras-MAP kinase signaling kinetics exhibited by the forward signaling of EphA4 in PC12 cells. 
INTRODUCTION
The Eph family is comprised of at least sixteen different receptors and nine different ligands, and they regulate diverse developmental patterning processes, including axon guidance, cell migration, and cell segregation (1) (2) (3) . In contrast to other receptor tyrosine kinases (RTKs), Eph RTKs do not regulate cell proliferation and survival in the presence of ephrin stimulation. Rather, activation of Eph receptors by their cognate ligands leads to changes in cell adhesion by regulating cytoskeletal proteins (4) (5) (6) .
The mitogen-activated protein kinases (MAPKs) have been shown to be essential for cellular proliferation and differentiation (7) . Both the magnitude and longevity of MAPK activation governs the nature of the cellular response, particularly in PC12 cells (8) . For example, EGF provokes a transient activation of the MAP kinases, leading to an increase in mitotic rates (9) . In contrast, NGF treatment results in sustained activation of the MAP kinases, inducing differentiation into a sympathetic neuron-like phenotype (10) . The question of how various factors elicit distinct biological responses through common signaling transduction components such as MAP kinases is of considerable interest, in particular during developmental processes.
Recent studies revealed that the MAPK pathway is involved downstream of activated Eph receptors. For example, ligand binding to EphA2 and EphB1 promotes the activation of the MAPK signaling cascade through recruitment of the adaptor proteins, Grb2 and Shc (11, 12) . Moreover, EphB1 interacts with Nck and Ste20 kinase NIK (Nck-interacting protein) upon ligand stimulation, thereby activating c-Jun NH2 terminal kinase (JNK) (13) . In contrast to these results, some studies show that Eph receptors negatively regulate the MAPK signaling pathway. For example, ligand activated EphB2 inhibits Ras and MAPKs, eading to neurite retraction in NG108-15 cells (14) . In this signaling pathway, binding between p120 Ras GAP and EphB2 is important for downregulation of the Ras-MAPK signaling and neurite retraction (15) . More recently, it has been shown that the EphA8 receptor induces sustained MAP kinase activation to promote neurite outgrowth in neuronal cells (16) . These controversial discrepancies in differential effects on MAP kinases by Eph receptors may result from using different cell types and/or varying degrees of Eph receptor over-expression. It may be more physiologically relevant to determine the mechanism regulating MAPK activation using endogenously expressed Eph receptors.
In this report, we show that the EphA4 receptor is endogenously expressed in PC12 cells, and that ligand-activated EphA4 receptor plays an important role in activating the Ras-MAPK cascade. Our results suggest that Ephrin-A5 stimulation induces transient activation of Ras-MAPK signaling, possibly through rapid internalization of the EphA4/ephrin-A5 complexes in PC12 cells. More importantly, the magnitude of the MAPK activation induced by ephrin stimulation is 3-fold less than that by EGF, possibly explaining why ephrin stimulation fails to increase the mitotic rate of PC12 cells.
RESULTS

Treatment with ephrin-A5 induces a transient increase in MAP kinase activity in PC12 cells
Previous studies indicated that activation of Eph-related re-http://bmbreports.org ceptors regulates MAP kinase signaling pathway positively or negatively, depending on cell type or Eph receptor used in the experiments (16) . To determine whether ephrin-A5 is able to affect MAP kinase signaling pathway in PC12 cells, serum-starved cells were treated with preclustered ephrinA5-Fc for various times as indicated in Fig. 1A . Cell lysates were then directly analyzed by Western blot using anti-phosphoMAP kinase antibody (first panel) or anti-MAP kinase antibody (second panel). Quantitation using densitometric analyses revealed that ephrin-A5 stimulated MAP kinase activity by 2-fold after 10 min of treatment (Fig. 1B) . Consistent with previous results (8) , EGF treatment of PC12 cells resulted in a robust increase in MAP kinase activity by 6-fold after 5 min of treatment ( Fig. 1C and D). Taken together, our results demonstrated that both EGF and ephrin-A5 are able to induce a transient increase in MAP kinase activity, although the effects of ephrin-A5 were much less than that of EGF.
The EphA4 receptor is transiently activated by ephrin-A5 stimulation in PC12 cells
To further assess which Eph receptors are stimulated by ephrin-A5 treatment, total RNA was extracted from PC12 cells and RT-PCR was performed using specific primers designed to amplify each of the 15 different Eph receptors (see Materials and Methods). Our experimental approach suggested that EphA4 is the only Eph receptor expressed in PC12 cells (data not shown). Consistent with this prediction, Western blot analysis using a specific anti-EphA4 antibody clearly demonstrated that the EphA4 receptor is endogenously expressed in PC12 cells ( Fig. 2A) . To further investigate whether ephrin-A5 treatment increases tyrosine phosphorylation of EphA4, cells were stimulated with preclustered ephrin-A5 for various times. Cell lysates were immunoprecipitated with an anti-EphA4 antibody and the precipitates were analyzed by Western blot using an anti-phosphotyrosine antibody ( Fig. 2A, top panel) or an anti-EphA4 antibody ( Fig. 2A, bottom panel) . As shown in Fig.  2B , tyrosine phosphorylation of EphA4 in response to ephrin-A5 treatment was enhanced by 4-fold after 10 min of treatment, and then gradually decreased. Taken together, our results strongly indicated that ephrin-A5 stimulated MAP kinase activity by inducing tyrosine phosphorylation of the EphA4 receptor.
Ras plays a pivotal role in ephrin-A5-induced MAP kinase activation in PC12 cells
To investigate whether the activated EphA4 receptor triggers the Ras-MAP kinase signaling pathway, Ras activation was measured using the Ras binding domain (RBD) of c-Raf at various time points after ephrin-A5 stimulation. Cell lysates were incubated with Raf-RBD protein to recover GTP-bound Ras, and the precipitated Ras-GTP was specifically detected by Western blot using an anti-Ras antibody (Fig. 3A, lane 3) . Consistent with our findings that EphA4 and MAP kinases are transiently activated in response to ephrin-A5, the level of GTP-bound Ras was increased at least 1.5-fold after 10 min of ephrin-A5 treatment (Fig. 3B, third bar from left) . In EGF-treat-http://bmbreports.org BMB reports ed cells, GTP-bound Ras was elevated up to 2.3-fold after 5 min (Fig. 3A, lane 6) . In order to demonstrate that Ras activation is essential for ephrin-A5 induced MAP kinase activation, we tested PC12 cells stably expressing dominant negative mutant N17Ras. As shown in Fig. 3C and D, MAP kinase activity was not significantly altered by ephrin-A5 treatment at each time point. Taken together, we conclude that activation of EphA4 by ephrin-A5 leads to activation of the Ras-MAP kinase signaling pathway.
The EphA4 receptor is internalized by endocytosis upon engagement of ephrin-A5
The results in Fig. 2 indicate that the EphA4 receptor level in PC12 cells was significantly reduced by ephrin-A5 treatment.
Recently it was reported that upon ligand binding, Eph receptors are internalized by a clathrin-dependent mechanism (17, 18) . Endocytosis of EphA4 may cause termination of the activated Ras-MAP kinase signaling pathway at the cell surface, possibly because it is degraded in the endosome. To investigate whether the EphA4 receptors are internalized by endocytosis of EphA4/ephrin complex, surface bound or in-http://bmbreports.org (Fig. 4) . This result strongly suggests that interaction of ephrin-A5 with EphA4 triggers a transient activation of the Ras-MAP kinase signaling pathway, and that its initial activation is terminated by endocytosis of the EphA4 receptor.
DISCUSSION
In the present study, we demonstrate that EphA4 activation by ephrin-A5 in PC12 cells plays an important role in triggering the Ras-MAPK signaling pathway. Transient activation of Ras-MAPK signaling by ephrin-A5 is a novel finding. Significantly, ephrin-A5 is internalized into the cytoplasm upon its binding to endogenous EphA4 receptor in PC12 cells. We found that the kinetics of ephrin-A5-induced MAPK activation is similar to that of EGF-stimulated MAPK activation in PC12 cells. However, the magnitude of MAPK activation by ephrin stimulation is at least 3-fold less than that by EGF stimulation. Although the data are not shown here, we found that unlike EGF and NGF, treatment with ephrin-A5 had no effects on PC12 proliferation or differentiation of PC12 cells. These findings lead us to hypothesize that the endogenously-expressed EphA4 receptor in PC12 cells initiates a novel signaling mechanism to regulate the magnitude and longevity of the Ras-MAP kinase signaling pathway that has not been observed in other growth factor-triggered signaling pathways. These findings raise three important issues, including: (i) the mechanism by which internalization of EphA4-ephrin-A5 complex terminates Ras-MAP kinase signaling pathway, (ii) the effectors biochemically linking the activated EphA4 receptor with activation of the Ras-MAP kinase signaling pathway, and (iii) the biological relevance of EphA-stimulated MAPK activation in PC12 cells.
The first concern is how endocytosis of the EphA4/ephrin complex is connected to the attenuation of the Ras-MAP kinase signaling pathway. The transient activation of the Ras-MAP kinase signaling pathway in ephrin-A5 stimulated cells is similar to that in EGF-treated cells. This suggests that transient activation of the Ras-MAP kinase signaling results from a similar mechanism in EGF or ephrin-A5 treated cells. EGF is released from the EGF receptor upon endosome acidification, thereby causing termination of the Ras-MAP kinase signaling pathway (19) . It remains to be further determined whether ephrin-A5 is released from EphA4 within the endosome. Alternatively, the EphA4 receptor may be very unstable within the endosome, since the level of EphA4 was significantly reduced after ephrin-A5 stimulation. Reduced EphA4 level may result from internalization of EphA4, followed by degradation in the endosome or lysosome.
The second concern is regarding the biochemical linkers connecting the activated EphA4 receptor to Ras activation in PC12 cells. Previous studies showed that ligand binding to EphA2 and EphB1 promote the MAPK signaling cascade through recruitment of the adapter proteins, Grb2 and Shc (11, 12) . It is also possible that activated EphA4 receptor associates with Grab2 or Shc to activate Ras-MAP kinase signaling pathway in PC12 cells. However, we were not able to demonstrate an association between EphA4 and these adapter proteins, possibly because the EphA4 endogenous expression levels are very low in PC12 cells. Alternatively, the EphA4 receptor may associate with other adapter proteins to regulate the Ras-MAP kinase signaling pathway, which remains to be elucidated in our future work.
The final issue is the biological relevance of EphA-stimulated MAPK activation in PC12 cells. It has been well known that Eph receptors play a pivotal role during axon pathfinding and neural circuitry formation. Based on these observations, one plausible function of the EphA4-induced MAPK activation in PC12 cells is to regulate the rearrangement of the actin cytoskeleton through the possible connection with regulation of Rho family GTPases. Although EphA4-induced MAPK activation does not cause the differentiation of PC12 cells, it may transiently regulate the extension or collapse of neurite tips in differentiated PC12 cells induced by NGF. In this aspect, PC12 cells may provide a good cell culture system to study how the EphA4 receptor may regulate behavior of the axonal growth cone.
MATERIALS AND METHODS
Cell culture, reagents and antibody PC12 cells were cultured in RPMI1640 (Hyclone) containing 5% FBS (Hyclone) and penicillin/streptomycin (Hyclone) in an atmosphere of 5% CO2 at 37 o C. For treatment with preclustered ephrinA5-Fc, purified Fc fusion protein was aggregated with anti-human Fc (Jackson Immunoresearch) for 30 min on ice. EGF was purchased from Promega. The polyclonal rabbit EphA4-antibodies, anti-phosphotyrosine antibodies, anti-p42/44 antibodies and anti-phospho p42/44 antibodies were purchased from Cell Signaling. Anti-tubulin antibodies were purchased from Santa Cruz Biotechnology. TRITC-conjugated anti-human antibodies and HRP-conjugated secondary anti-rabbit antibodies were acquired from Chemicon and Zymed, respectively. AntiRas antibodies were purchased from BD science.
RT-PCR
For RT-PCR analysis, total RNA was extracted from PC12 cells using Trizol (Sigma) as described previously (20) . Reverse transcription was performed using Omniscript RT Kit and oligo (dT) primers at the suggested conditions (Qiagen). The resulting cDNA was then used for PCR to amplify various Eph genes using the following primer sets: for EphA1, 5'-GCCAGGAACATCTTGGT GAA-3' and 5'-TGAGCAGCTGTTCCAGATGT-3'; for EphA2, 5'-ATTCCTATTCGATGGACAGCCC-3' and 5'-ACTCAGACAC CGTCCGGAAG-3'; for EphA3, 5'-GAGTTACGGGATTGTACT
Immunoprecipitation, Western blotting and endocytosis assay
Immunoprecipitation and Western blotting were performed essentially as described previously (21) . For endocytosis assay, PC12 cells were seeded (3 × 10 5 ) into coverslips coated with 2 μg/ml of fibronectin (Sigma). After 24h, cells were serum stravated with media containing 0.5% FBS for 6 hours. Then, cells were treated with ephrinA5-Fc or Fc preclustered with goat anti-human Fc (2 μg/ml), gently washed twice with PBS, fixed with 4% paraformaldehyde/2% glucose in PBS for 20 min at room temperature, and rinsed three times for 5 min with TBST (50 mM Tris-HCl [pH 7.4], 150 mM NaCl, 0.1% Triton X-100). Cells were blocked with TBST containing 5% horse serum for 30 min at room temperature, further incubated with TRITC conjugated anti-human antibodies for 1h at room temperature, and washed three times with TBST. Cells were mounted with Vectashield (Vector laboratory) and observed using a confocal microscope (Olympus, FV300 model).
Ras activation assay
The oligomers 5'-GATCAGGATCCAAGACAAGCAACAC-3' and 5'-GATCAGTCGACACAGGAAATCTAC-3' have been used to amplify a fragment of the human c-raf-1. A 412 bp fragment was digested with BamHI/XhoI and then, subcloned into pGEX-5X-1. Purification of the glutathione S-transferase (GST) proteins was performed as described previously (21) . Ras activation assay was performed as described previously (22) . Briefly, PC12 cells were seeded (3 × 10 6 ) into 60 mm dish. After 24h, cells were serum starved with media containing 0.5% FBS for 6 hours, treated with ephrinA5-Fc or Fc preclustered with goat anti-human Fc at 5 μg/ml, and washed twice with HBS (25 mM HEPES [pH 7.5], 150 mM NaCl). Cells were lysed with lysis buffer (25 mM HEPES [pH 7.5], 150 mM NaCl, 1% NP-40, 1 mM EDTA, 10% glycerol, 25 mM NaF, 10 mM MgCl, 1 mM sodium vanadate, 10 μg of leupeptin/ml, 10 μg of aprotinin/ml, 0.1 mM phenylmethysulfonyl fluoride). Cell extracts were incubated with 10 μg of GST-Raf-RBD on ice for 1 hour, and incubated with glutathione beads for 2 hours. Bound Proteins were resolved by 12% SDS polyacrylamide gels and analyzed by Western blot us-http://bmbreports.org ing anti-Ras antibodies.
